Applied Therapeutics, Inc. - Common Stock (APLT)
1.2400
+0.6798 (121.35%)
NASDAQ · Last Trade: Sep 27th, 9:24 PM EDT
New York, NY – September 26, 2025 – Applied Therapeutics, Inc. (NASDAQ: APLT) ignited the biotech sector today, witnessing an astonishing stock surge of 103.50%. The dramatic leap comes on the heels of pivotal advancements for its lead drug candidate, govorestat (AT-007), targeting Charcot-Marie-Tooth Type 1A with Sorbitol Dehydrogenase (CMT-SORD) deficiency,
Via MarketMinute · September 26, 2025
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via Benzinga · September 26, 2025
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · September 26, 2025

Via Benzinga · December 23, 2024

Via Benzinga · December 6, 2024

Investors are cheering good news from the FDA.
Via The Motley Fool · September 18, 2024
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · September 26, 2025
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Via Benzinga · September 26, 2025
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · September 25, 2025
Via Benzinga · September 23, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · September 23, 2025
Via Benzinga · August 22, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · June 30, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · June 23, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · May 19, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · May 19, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · May 19, 2025

Adrian Alexandru files a securities lawsuit against Applied Therapeutics, alleging the company misled investors about clinical trials for govorestat.
Via Benzinga · December 20, 2024

Via Benzinga · December 2, 2024

Via Benzinga · November 29, 2024

Via Benzinga · November 29, 2024

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.
Via Benzinga · November 29, 2024